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Enrichment culture techniques produced more than 1200 isolates of lactic acid bacteria 
(LAB) that were screened for antifungal activity against the indicator mould Aspergillus 
fumigatus. Approximately 10% of the LAB were active, but only 4% had medium or strong 
activity in an agar plate assay. The majority of isolates with strong antifungal activity were 
Lactobacillus coryniformis strains, but Lactobacillus plantarum and Pediococcus 
pentosaceus were also frequently identified. Some of the isolates lost activity during storage 
but most maintained their fungal inhibitory effect. Large variations in sensitivity were 
observed between different moulds and yeasts. Antifungal cyclic dipeptides and 
phenyllactic acid were detected in culture filtrates from several of the LAB isolates.  
 
Lactobacillus coryniformis subsp. coryniformis strain Si3 produced an antifungal 
compound that lost activity when treated with proteases. The antifungal peptide(s) was heat 
stable, with a size of approx. 3kDa and had maximum activity at pH 3.0 to 4.5. Addition of 
ethanol to the growth medium of strain Si3 prevented a decline in observed antifungal 
activity during the stationary phase. Glycerol addition to agar plates with L. coryniformis 
strains, overlaid with soft agar suspensions of yeast cells or fungal spores, strongly 
enhanced the antifungal effect. This was particularly true with spoilage moulds and yeasts, 
e.g. Penicillium roqueforti and Pichia anomala, not normally affected by the antifungal 
metabolites of L. coryniformis. Chemical and genetic data suggested that reuterin (3-
hydroxypropionaldehyde) was the cause of this effect. The glycerol/diol dehydratase operon 
of L. coryniformis was partially elucidated and found to be similar to that Lactobacillus 
collinoides. 
 
Bioassay-guided isolation of new metabolites from LAB revealed that Lactobacillus 
plantarum MiLAB 14 produces hydroxylated fatty acids with strong antifungal effects.   
3-Hydroxydecanoic acid, 3-hydroxydodecanoic acid, 3-hydroxytetradecanoic acid and   
3-hydroxy-5-cis-dodecenoic acid were characterized from the supernatant of MiLAB 14. 
The hydroxy fatty acids had total inhibitory effects in the range 10 to >100 µg ml
-1 against 
several moulds and yeasts.  
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“A man who dares to waste an hour of life has not discovered the value of life" 
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Aims 
 
This thesis is an attempt to elucidate the complex nature of the antifungal activities 
of lactic acid bacteria. The primary hypothesis was that it should be possible to 
isolate lactic acid bacteria from natural habitats that inhibit growth of moulds and 
yeasts, through the production of substances other than lactic acid. Early during the 
investigations, it became clear that the focus of the work and the thesis itself would 
be the specific active compounds that were produced and not the effect on the 
fungus. This was mainly due to the surprisingly high number of antifungal 
compounds and the complexity of the antifungal effect.  
 
   The results are based on investigations of selected strains from more than 1200 
isolates of lactic acid bacteria from different environments. The overall hypothesis 
of this work can be divided into the following objectives: 
 
•  Establish methods for determination of antifungal activity (I, II) 
•  Isolate and identify lactic acid bacteria from natural environments that 
exert anti mould and/or anti yeast effects (I) 
•  Characterize the antifungal spectra of lactic acid bacteria (I, II) 
•  Isolate and chemically characterize antifungal compounds from lactic 
acid bacteria and determine the individual and synergistic effect against 
moulds and yeast. (II, III, IV) 
 
 
Introduction  
 
Lactic acid bacteria (LAB) were used in food and feed fermentation processes long 
before any knowledge of the presence of the bacteria themselves existed. It is 
impossible to say when man first used these processes, but old Egyptian murals 
show the production of silage several thousand years ago and fermentation as a 
preservative measure for food has also been present since historical times. The use 
of fermentation processes has increased during the centuries and includes many 
different kinds of animal feed and food (Ross, Morgan & Hill, 2002). However, it 
was only during the last century that we began to understand the metabolic 
processes behind the preserving effect of lactic acid bacteria.  During the last 
century it was realized that the lactic acid bacteria are responsible for the 
fermentation, and through that the (bio)preservative effect, utilized in many food 
and feed processes. Biopreservation refers to extended shelf life and enhanced 
safety of foods using the natural or added micro-flora and their antimicrobial 
products. 
 
  Lactic acid bacteria are found in many nutrient rich environments and occur 
naturally in various food products such as dairy and meat products, and vegetables 
(Carr, Chill & Maida, 2002). They have, by tradition, been established as a natural, 
consumer and environment friendly way of preserving food and feed. The 
preserving effect is mainly due to the reduction of pH through the production of   8 
 
lactic acid. Besides lactic acid, several other antimicrobial compounds are 
produced during growth of LAB (Lindgren & Dobrogosz, 1990). Research dealing 
with fungal inhibition by lactic acid bacteria and the compounds produced by these 
bacteria is still novel. While the number of publications regarding antibacterial 
activity of LAB is large, our knowledge of the antifungal activities of these 
bacteria is still limited.  
 
The combination of the increase of antibiotic resistance and a more general 
chemical resistance of pathogenic and/or spoilage organisms, together with an 
increasing general awareness among consumers calls for alternative measures to 
preserve food (Brul & Coote, 1999). There is a definite need for new ways to 
extend shelf life, suppress fungi, and produce safe, preservative free food. This 
need stimulates the search for lactic acid bacteria with these abilities. The long 
tradition of using lactic acid bacteria when processing food and feed, in 
combination with the more recent knowledge on positive health effects caused by 
ingestion of probiotic LAB (Mattila-Sandoholm, Mättö & Saarela, 1999; 
Andersson et al., 2001), makes them an promising alternative. 
 
 
Fungal spoilage of food and feed  
 
Ergotism, or St. Anthony´s fire (originally “Holy Fire”), was documented as a 
common human disease around the 10:th century. The origin of the disease 
remained a mystery until the mid 19:th century when it was discovered that it was 
caused by production of the ergot toxin from the fungus Claviceps purpurea on 
cereals. St. Anthony's fire is a toxic condition with symptoms including 
hallucinations, disorientation, muscle cramps, convulsions, miscarriages, and 
gangrene and may result in death. The large consumption of grain infected with 
sclerotia of C. purpurea caused several thousand deaths in the 10:th and 11:th 
century in central Europe and these fungal infections were possibly the reason for 
reduced fertility in Europe prior to 1750 (Pohland, 1993; van Dongen & de Groot, 
1995; Packer, 1998). In the mid 20:th century another fungal toxin, aflatoxin, was 
reported from the fungus Aspergillus flavus (Filtenborg, Frisvad & Thrane, 1996). 
Several of the aflatoxin derivates have strong carcinogenic properties. They can be 
formed on a number of substrates, such as oilseeds and nuts, and certain 
subtropical fruits, e.g. figs. In the mid 1960´s, an outbreak of aflatoxin poisoning 
occurred in Great Britain, commonly called “Turkey X-disease”, that lead to the 
death of more than 100 000 turkeys (van Egmond, 2000). Today, more than 400 
mycotoxins are known from many different fungal genera and the number is 
increasing rapidly (Filtenborg, Frisvad & Thrane, 1996). 
 
In addition to health hazards from mycotoxins, contaminating moulds cause 
considerable general spoilage of food and feed. Filamentous moulds and yeasts are 
common spoilage organisms of food products as fermented milk products, cheese, 
bread, stored crops and feed such as hay and silage  (Bullerman, 1977; Moon, 
1983; Bonestroo et al., 1993; Filtenborg, Frisvad & Thrane, 1996). It is estimated 
that between 5 and 10% of the world’s food production is lost due to fungal   9 
 
detoriation (Pitt & Hocking, 1999). In Western Europe, mould spoilage of bread 
alone is estimated to cause an annual economical loss of about £242 million 
(Corsetti et al., 1998).  
 
Penicillium and Aspergillus species have been reported as spoilage organisms 
during storage a wide range of food and feeds and Fusarium species are often 
found on cereal grains, where they might produce a number of mycotoxins 
(Filtenborg, Frisvad & Thrane, 1996; Samson et al., 2000). Different Penicillium 
species frequently occur in foods stored under cold conditions, and P. roqueforti 
and  P. commune commonly spoil hard cheese (Filtenborg, Frisvad & Thrane, 
1996, Pitt & Hocking, 1999). Yeasts such as Candida parapsilosis, Rhodotorula 
mucilaginosa, Kluyveromyces marxianus and Debaromyces hansenii are common 
spoilage organisms of youghurt and other fermented dairy products (Pitt & 
Hocking, 1999; Loureiro & Querol, 1999).  
 
 However, yeasts also play an essential role in the preparation of certain dairy 
products and in the ripening of various cheeses where they contribute substantially 
to the characteristics of the final product. Yeasts contribute to the fermentation by 
supporting the lactic acid bacterial starter culture, inhibiting unwanted 
microorganisms, or adding desirable biochemical changes to the final product e.g. 
cheese (Viljoen, 2001). Some moulds e.g. P. roqueforti and P. camemberti are also 
essential for the production of soft cheese (Samson, 2000). 
 
 
Traditional fungal control and the search for a 
natural alternative 
 
Several techniques are used for the preservation of food and feed. Drying, freeze-
drying, cold-storage, modified atmosphere storage, and heat treatments are all 
means of physical methods of food preservation (Farkas, 2001). Several chemical 
additives also function as preservatives, even though the exact mechanisms or 
targets often are not known (Davidson, 2001). Many organic acids are used as food 
additives, the most active are acetic, lactic, propionic, sorbic and benzoic acids 
(Brul & Coote, 1999). Both sorbic and benzoic acid have a broad spectrum of 
activity (Nielsen & Deboer, 2000; Davidson, 2001). Benzoic acids and sodium 
benzoate are used primarily as antifungal agents (Davidson, 2001). Natamycin is 
an antibiotic agent produced by Streptomyces natalensis that is very effective 
against yeasts and moulds and often used as preservative on surfaces of hard 
cheese (Davidson, 2001). 
 
It is a well-known fact that increasing amounts of microorganisms are becoming 
resistant to antibiotics. Fungi are no exception and more species of both human 
fungal pathogens and spoilage moulds in food and feed systems are becoming 
resistant. However, yeasts and moulds are not only becoming resistant to 
antibiotics, but also to preservatives such as sorbic and benzoic acids, as well as 
chemical treatment with cleaning compounds (Brul & Coote, 1999; Loureiro, 
2000; Viljoen, 2001; Sanglard, 2002). High initial mould populations can degrade   10 
 
sorbic acid in cheese and a number of Penicillium,  Saccharomyces and 
Zygosaccharomyces  species can grow in presence of and degrade potassium 
sorbate (Davidsson, 2001). The number of moulds degrading sorbate is increasing 
(Nielsen & Deboer, 2000). In addition, isolates of P. roqueforti have been found to 
be resistant to benzoate (Nielsen & Deboer, 2000). 
 
The mould Penicillium discolor has recently acquired resistance to chemicals 
used in food processing, e.g. natamycin (Nielsen & Deboer, 2000; Cabo, Braber & 
Koenraad, 2002). P. discolor can grow on high concentrations of natamycin and 
cause spoilage on hard cheese (Filtenborg, Frisvad & Thrane, 1996, Nielsen & 
Deboer, 2000). Yeast like Debaromyces hansenii, Candida versatilis and 
Torulaspora delbrueckii, have also shown strong resistance to chemical sanitizers 
and cleaning compounds in dairy environments (Viljoen, 2001).  There is a great 
risk that the resistance phenomenon will increase in the future due to the frequent 
use of antibiotics and preservatives. It is therefore essential to develop good 
alternatives.  
 
The general public wants to reduce the use of chemical preservatives or additives 
in food or feed. Instead, consumers require high quality, preservative free, safe but 
mildly processed food with extended shelf life (Brul & Coote, 1999). This is of 
course not an easy task to solve. In addition, present legislation has restricted the 
use of some currently accepted preservatives in different foods (Brul and Coote 
1999). This is also one important aspect to bear in mind when discussing the need 
for novel preservation methods to inhibit the growth of unwanted fungal 
contamination.  
 
Lactic acid bacteria occur naturally in foods or are added as pure cultures to 
various food products. They are considered to be harmless or even to have an 
advantage for human health (probiotics). LAB have a GRAS affirmation 
(generally recognized as safe) and have, through tradition, been established as a 
natural consumer and environmental friendly way to preserve food and feed. It has 
been estimated that 25% of the European diet and 60% of the diet in many 
developing countries consists of fermented foods (Stiles, 1996).  LAB are well 
known for their use as starter cultures in the manufacture of dairy products such as 
acidophilus milk, yoghurt, buttermilk, cottage cheeses, hard cheeses (Cheddar and 
Edam) and soft cheeses (Brie and Camembert) among others (Carr, Chill & Maida, 
2002). Lactic acid bacteria used in milk fermentations, especially Lactococcus 
lactis are among the best characterized in the group. Lactobacillus and 
Leuconostoc species are also associated with milk products (Stiles, 1996).  
 
The coexistence of lactic acid bacteria and fungi is essential for the success of 
several biotechnological applications e.g. sourdough bread making, where the ratio 
of lactic acid bacteria/yeast is generally 100:1 (Gobbetti, 1998). Even though LAB 
are essential for the production of several fermented food and feed products they 
can also exist as spoilage organisms causing economical loss. Makanjuola, Tymon 
& Springham (1992) found that Lactobacillus plantarum caused flocculation of 
fermentation yeast, and thereby reduced ethanol production in whisky 
fermentations. Lactobacillus and Pediococcus species have been reported to act as   11 
 
spoilage organisms during fermentation of beer (Jespersen & Jakobsen, 1996), and 
certain species of Lactobacillus are known to spoil wine and cider through the 
production of acrolein (Claisse & Lonvaud-Funel 2000). 
 
 
What is a lactic acid bacterium? 
 
Taxonomy 
The term lactic acid bacteria (LAB) was gradually accepted in the beginning of the 
20:th century. Other terms as “milk souring” and “lactic acid producing” bacteria 
had previously been used for the same bacteria causing a slight confusion. This 
ended with publication of a monograph about lactic acid bacteria written by Orla-
Jensen, 1919, a work that had great impact on the systematics of LAB. 
Classification of LAB genera was based on morphology, mode of glucose 
fermentation, growth at certain temperatures, and range of sugar utilization. Even 
though the taxonomy has been revised since then, characters used by Orla-Jensen, 
are still very important in current classification of LAB (Axelsson 1998). 
 
Lactic acid bacteria constitute a group of bacteria that have morphological, 
metabolic and physiological similarities, and they are also relatively closely related 
phylogenetically. The general description of the bacteria within the group is Gram-
positive, non-sporulating, non-respiring cocci or rods, which do, through 
fermentation of carbohydrates, produce lactic acid as their major end product. The 
common agreement is that there is a core group consisting of four genera; 
Lactobacillus, Leuconostoc, Pediococcus and Streptococcus. Recent taxonomic 
revisions have proposed several new genera and the remaining group now 
comprises the following: Aerococcus, Alloiococcus Carnobacterium, 
Dolosigranulum, Enterococcus, Globicatella, Lactococcus, Oenococcus, 
Tetragenococcus, Vagococcus, and Weissella. Lactobacilli, carnobacteria and 
some weissella are rods while the remaining genera are cocci (Axelsson, 1998).  
 
For identification of lactic acid bacteria, phenotypic methods have been most 
commonly used. More recently, genetic techniques, such as 16S rDNA sequencing 
have been developed which allows a more consistent and accurate identification of 
individual strains. Determination of short sequences of 16S rDNA is today used as 
a simple way for species determination of isolates of lactic acid bacteria (Schleifer 
& Ludwig, (1995). 
 
Metabolism 
Lactic acid bacteria have two different metabolic pathways for hexose 
fermentation, the homo- and heterofermentative pathway. The homofermentative 
pathway follows the glycolysis (Embden-Meyerhof-Parnas pathway), and occurs 
among  Lactococcus,  Streptococcus,  Pediococcus, and homofermentative 
Lactobacillus species. It is characterized by the splitting of fructose-1,6-
diphosphate (FDP) into two triose phosphate moieties, glyceraldehyde-3-  12 
 
phosphate (GAP), and dihydroxyacetonephosphate (DHAP) in equilibrium, by a 
FDP aldolase. GAP is further converted to pyruvate, which is then reduced to 
lactic acid (Axelsson, 1998; Kandler, 1983). 
 
The heterofermentative, or the 6-phosphogluconate / phosphoketolase pathway 
is characterized by the oxidation of glucose 6-phosphate to gluconate 6-phosphate 
followed by decarboxylation. The remaining pentose is split into a C-3 moiety 
(glyceraldehyde-3-phosphate) and a C-2 moiety (acetyl-phosphate) by a 
phosphoketolase. As a result, equimolar amounts of CO2, lactate and ethanol are 
formed from hexose. Heterofermentative lactic acid bacteria generally ferment 
pentoses, although there are some pentose negative strains (Kandler, 1983). 
Heterofermentative LAB also possesses the ability to use external electron-
acceptors to regenerate NADH, and hence gain more energy. Because of this 
alternative pathway, acetate will be formed instead of ethanol (Axelsson, 1998). 
One group of lactic acid bacteria has the ability to use both pathways but prefers 
the homofermentative pathway in presence of hexoses (Axelsson, 1998; Kandler, 
1983). 
 
 
 
 
 
 
 
 
 
 
 
Habitats 
Lactic acid bacteria are commonly found and known to proliferate in fermentation 
processes or as colonizers of mucosal surfaces of higher animals. They require a 
nutrient rich environment in order to establish. Besides carbohydrates, they also 
need to be supplied with amino acids, peptides, salts and vitamins among others 
(Hammes, Weiss & Holzapfel, 1992; Carr, Chill & Maida, 2002).  
 
Homofermentation 
    1 Hexose + 2ADP + 2Pi Æ 2 Lactate + 2 ATP 
 
Heterofermentation 
  1 Hexose + 1 ADP + Pi Æ Lactate + Ethanol + CO2 + 1 ATP  
    or (if external e- acceptor) 
    1 Hexose + 2 ADP + Pi Æ Lactate + Acetate + CO2 + 2 ATP   13 
 
Antifungal activities of lactic acid bacteria 
 
Lactic acid bacteria produce a variety of compounds with antimicrobial activity. 
Lactic and acetic acids are produced as end products during lactic acid bacterial 
fermentation causing a reduction in pH, but other substances such as hydrogen 
peroxide, formic acid, propionic acid, acetoin and diacetyl, are also produced   
(Lindgren & Dobroqosz, 1990).  
 
The precise mechanism of antimicrobial action can often not be defined because 
of a complex interaction between different compounds. Synergistic effects are 
often seen between the compounds involved in the antimicrobial action (Corsetti et 
al., 1998; Niku-Paavola et al., 1999). Much research has been directed towards 
identifying different antimicrobial substances, primarily antibacterial, in simple in-
vitro systems, but little is known about the overall mechanisms of complex 
preservation systems within food and feed environments (Earnshaw, 1992). 
Studies on the effect of LAB on fungi are complicated by the fact that some fungi 
are sensitive to the normal by-products of LAB-metabolism, most notably lactic 
and acetic acids (Lindgren & Dobroqosz, 1990; Piard & Desmazeaud, 1992; 
Bonestroo et al., 1993). 
 
In the following sections, the inhibitory compounds are described under three 
headings; fermentation products, proteinaceous compounds and low molecular 
weight inhibitory compounds. The section ends with a summary of the current 
knowledge of antifungal compounds from LAB. The literature review is combined 
with a summary of results obtained within this thesis work. The number of 
publication about antifungal activity of lactic acid bacteria is low. Reviewing the 
area reveals the fact that a majority of the publications describe activity of lactic 
acid bacteria, and that only very few present any characterization of compounds or 
mechanisms. A summary of publications on antifungal lactic acid bacteria is 
presented in table 1. 
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Table 1. Compilation of publications reporting antifungal activity of lactic acid bacteria 
(ND = Not determined) 
 
 
LAB isolate* 
 
Activity spectrum 
 
Compound(s) 
 
Reference 
Streptococcus lactis C10 
 
Aspergillus parasiticus  ND  Wiseman & Marth 
(1981) 
Lactobacillus casei  
ATCC 393 
Aspergillus parasiticus  ND  El-Gendy & Marth 
(1981) 
S. lactis 
 
Aspergillus flavus 
 
ND 
 
Coallier-Ascah & 
Idziak (1985) 
L. casei var. rhamnosus  Broad spectrum  ND  King & Vanderbergh 
(1986) 
L. casei var. rhamnosus  Broad spectrum  < 1kDa  Vanderbergh & King 
(1988) 
Lactobacillus reuteri  Broad spectrum  3-HPA (reuterin)  Talarico et al. (1988); 
Chung et al. (1989) 
Lactobacillus plantarum 
 
Unspecified spoilage 
mould 
ND Hill  (1989) 
S. lactis subsp. diacetilactis 
DRC1 
 
Aspergillus fumigatus, 
Aspergillus parasiticus, 
Rhizopus stolonifer, 
Possibly proteinaceous  Batish, Grover & Lal 
(1989) 
Pediococcus acidilactici 
 
Saccharomyces cerevesiae  Possibly proteinaceous  Vanderbergh & Kanka 
(1989) 
Lactobacillus acidophilus R  Aspergillus fumigatus  ND  Batish, Lal & Grover 
(1990) 
Lactococcus lactis  Aspergillus parasiticus  ND  Luchese & Harrigan 
(1990) 
L.casei subsp. rhamnosus 
L. plantarum 
Leuconocstoc mesenteroides 
Penicillium spp., 
Aspergillus spp.  
ND  Suzuki, Nomura & 
Morichi (1991) 
L. plantarum 
 
Saccharomyces cerevisiae  ND Makanjoula,  Thymon 
& Springham (1992) 
L.casei subsp. rhamnosus  
LC-705 
 
 
 
Candida lusitaniae, 
Aspergillus niger, 
Fusarium spp., 
Penicillium spp., 
Cladosporium spp. 
ND Mäyrä-Mäkinen  et al. 
(1994) 
L. lactis subsp. lactis CHD 
28.3 
Aspergillus flavus,  
A. parasiticus,  
Fusarium spp. 
Possibly proteinacious  Roy et al. (1996) 
L. casei  Penicillium spp.  Possibly proteinaceous  Gourama (1997)   15 
 
 
LAB isolate* 
 
Activity spectrum 
 
Compound(s) 
 
Reference 
Lactobacillus casei subsp. 
pseudoplantarum 
Aspergillus flavus  Possibly proteinaceous, 
<1kDA 
Gourama & Bullerman 
(1995; 1997) 
Lactobacillus sanfrancisco 
CB1 
Fusarium spp., 
Penicillium spp., 
Aspergillus spp., 
Monilia spp. 
Caproic acid,  
propionic acid,  
butyric acid,  
valeric acid 
Corsetti et al. (1998) 
L. plantarum VTT E78076 
 
 
 
Fusarium avenaceum  Benzoic acid, 
methylhydantoin, 
mevalonolactone, 
cyclo(Gly-L-Leu), 
Niku-Paavola et al. 
(1999) 
Lactobacillus pentosus  Candida albicans  Pentocin TV35b  Okkers et al. (1999) 
L. casei, 
Lactobacillus delbrueckii 
subsp. bulgaricus, 
L. lactis subsp. cremoris 
Penicillium expansum  ND Florianowicz  (2001) 
L. plantarum  Broad spectrum  Phenyllactic acid,  
4-hydroxyphenyllactic 
acid 
Lavermicocca (2001) 
L. rahmnosus 
 
 
 
Penicillium spp., 
Aspergillus spp., 
Fusarium spp.,  
Alternaria spp. 
Sodium acetate
1 Stiles  et al. (2002) 
L. plantarum MiLAB 393 
 
 
Broad spectrum  3-Phenyllactic acid, 
cyclo(Phe-Pro),  
cyclo(Phe-OH-Pro)   
Ström et al. (2002) 
Lactobacillus coryniformis 
Si3  
 
 
Broad spectrum  Peptide, 
phenyllactic acid, 
cyclo(Phe-Pro),  
cyclo(Phe-OH-Pro), 
reuterin 
I, II, IV 
L. plantarum MiLAB14 
 
Broad spectrum  Hydroxy fatty acids,   
phenyllactic acid, 
cyclo(Phe-Pro),  
cyclo(Phe-OH-Pro), 
II, III, Unpublished 
results 
Pediococcus pentosaceus 
MiLAB 24 
Broad spectrum  Cyclo(phe-OH-Pro)  Unpublished results,  
* Some species have through taxonomic revisions, received new species identities, which 
are not taken into account here.  
1. Sodium acetate from the MRS substrate was involved in the inhibitory action of lactic 
acid bacteria towards several moulds; the additional effect of other compounds was not 
determined. 
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Fermentation products 
Organic acids 
The major metabolite of lactic acid bacteria is lactic acid, which is responsible for 
the significant pH changes in their growth environment – sufficient to antagonize 
many microorganisms (Eklund, 1989). The undissociated form of the weak organic 
acid diffuses over the cell membrane and is, depending on intracellular pH, more 
or less dissociated inside the cell, releasing H
+-ions that acidify the cytoplasm 
(Axelsson, 1990; Piard & Desmazeaud, 1991). In addition to the pH effect, the 
undissociated form of the molecule mediates the antimicrobial effect of collapsing 
the electrochemical proton gradient causing bacteriostasis and eventual death of 
the susceptible bacteria (Eklund, 1989). The effect is more pronounced at pH 
values below the pKa value of the acid, i.e. when the acid is in undissociated state 
(Axelsson, 1990; Piard & Desmazeaud, 1991). Reiss (1976) observed that 0.75% 
lactic acid (approx. 80 mM) reduced the growth of Aspergillus parasiticus, while 
El-Gazzar, Rusul & Marth, (1987) found that lactic acid up to concentrations of 
2% (200 mM) supported the growth of Aspergillus parasiticus. This difference 
could be due either to different tolerance to organics acids between strains or to 
variations in their experimental designs. 
 
Heterofermentative LAB produces acetic acid in presence of external electron 
acceptors in relatively high amounts, whereas propionic acid is only produced in 
trace amounts. Both acids have higher pKa values than lactic acid and therefore 
have a higher proportion of undissociated acid at a certain pH. Similar to lactic 
acid, acetic and propionic acid interact with cell membranes to neutralise the 
electrochemical proton gradient, but the effect of acetic and propionic acid is often 
dependent on the decrease in pH caused by lactic acid (Freese, Sheu & Galliers, 
1973; Eklund, 1989). Propionic acid negatively influence fungal growth, especially 
at lower pH (Woolford, 1984a), and affect fungal membranes at pH values below 
4.5 (Hunter & Segel, 1973). Propionic and acetic acid also inhibit amino acid 
uptake (Freese, Sheu & Galliers, 1973; Eklund, 1989). Some salts of propionic 
acid, such as sodium propionate and ammonium propionate show a similar effect 
against yeast and filamentous moulds at low pH (Woolford, 1984b). Moon (1983) 
found that mixtures of high concentrations of lactic, acetic and propionic acid 
inhibited yeast species that normally grow well in relatively high concentrations 
(100 mM) of the individual acids, except for propionic acid.  
 
The combination of lactic acid produced during LAB growth and the sodium 
acetate of de Man, Rogosa, Sharpe (MRS) substrate (De Man, Rogosa & Sharpe, 
1960) a standard growth medium for LAB, has synergistic antifungal effects. 
(Cabo, Braber & Koenraad, 2002; Stiles et al., 2002). The sodium acetate in MRS 
might also have synergistic effects with additional antifungal compounds produced 
by LAB (Stiles et al., 2002). Similar effects have been detected in this work 
(unpublished). However, we also found that non-inhibiting lactic acid bacteria 
produced more lactic acid than highly active ones (I). Anyhow, the inhibitory 
effects of organic acids such as lactic, acetic and propionic acid will continue to   17 
 
complicate studies on antimicrobial effects of lactic acid bacteria, unless rigorous 
further purification and characterization of substances is applied (I, II, III, IV). 
 
Other end products 
Most LAB possess flavoprotein oxidases (and NADH peroxidases), which enables 
them to produce hydrogen peroxide (H2O2) in the presence of oxygen. Hydrogen 
peroxide accumulates in the environment since LAB not produces catalase 
(Condon, 1987). The antimicrobial effect of hydrogen peroxide is well 
documented (Davidsson et al., 1983) and attributed to a strong oxidizing effect on 
the bacterial cell, and to the destruction of basic molecular structures of cellular 
proteins. The antimicrobial effect of hydrogen peroxide, even though the 
concentration itself is not inhibitory, may be potentiated by the presence of 
lactoperoxidase and thiocyanate in natural environments such as milk and saliva 
(Condon, 1987). The lactoperoxidase-thiocyanate-peroxide system involves the 
reaction of hydrogen peroxide and thiocyanate through the catalysis by 
lactoperoxidase. The intermediary products such as hypothiocyanate act inhibitory 
to other microorganisms. Lactoperoxidase and thiocyanate are present in milk, and 
when some LAB are grown in milk or milk products, the third needed component, 
hydrogen peroxide, is added (Björck et al., 1975; Björck, 1978). Fitzsimmons & 
Berry (1994) reported the inhibitory effect of this system against Candida 
albicans. Rodríguez et al. (1997) suggested that MRS should be used as substrate 
when screening for antimicrobial substances other than hydrogen peroxide. They 
found that hydrogen peroxide is rapidly degraded in MRS, probably due to 
catalase activity of the yeast extract.  
 
Diacetyl (2,3-butanedione) is the molecule responsible for the characteristic 
aroma associated with butter. It is produced by strains of all genera of lactic acid 
bacteria during citrate fermentation (Earnshaw, 1992). The antimicrobial effect of 
diacetyl is well documented, especially at pH below 7.0 (Jay, 1982). However, the 
amount of diacetyl needed to exert antimicrobial activity (close to 200 mM) will 
dramatically alter the taste and aroma of the product (Piard & Desmazeaud, 1991). 
 
Proteinaceous compounds 
Ribosomally synthesised antimicrobial peptides are found in a broad range of 
organisms, such as mammals, birds, amphibians, insects, plants and 
microorganisms. Although the group of antimicrobial peptides is diverse, they 
generally share some features; a hydrophobic and a hydrophilic end, a size of 20-
50 amino acids, and cationic properties (Nissen-Meyer & Nes, 1997; Hildeng-
Hauge, 1998). LAB produce antibacterial, ribosomally synthesised, peptides, 
generally termed bacteriocins (Nes et al., 1996). Already in 1928, Roger and 
Whittier reported the first well-documented antimicrobial peptide, nisin, produced 
by a strain of Lactococcus lactis (Hirch et al., 1951).  
 
A large number of bacteriocins have been characterized from lactic acid bacteria 
in recent years. The bacteriocins from lactic acid bacteria are commonly divided 
into three groups: class I – the lantibiotics; class II – the heat stable unmodified   18 
 
bacteriocins; class III the larger heat stable bacteriocins (Nes et al., 1996; Nes & 
Holo, 2000). These compounds are generally only active against closely related 
bacterial species and there is no evidence that bacteriocins have any effect on 
growth of yeast or moulds.  
 
In contrast, there are only few reports on the production on antifungal peptides 
produced by lactic acid bacteria. Several authors have reported that the antifungal 
activity of LAB is lost after treatment with proteolytic enzymes. Batish, Grover & 
Lal (1989) claim that the antifungal substance produced by a lactic acid bacterium 
included in their study was of proteinaceous nature since it was degraded by 
proteinases. However, they did not present any results supporting these claims and 
did not characterise the active compound in any detail. Roy et al., (1996) isolated a 
Lactococcus lactis subsp. lactis with antagonistic activity against several 
filamentous fungi. After enzymatic treatment with chymotrypsin, trypsin and 
pronase E, the antifungal activity disappeared, indicating a proteinaceous nature of 
the antifungal substance. The substance was not characterized further. Gourama 
(1997) found that the inhibitory effect of a Lactobacillus casei strain against two 
Penicillium species was slightly reduced by treatment with trypsin and pepsin, but 
the compound was not characterized further. 
 
Gourama & Bullerman (1995, 1997) showed that a commercially available 
silage inoculant with a combination of Lactobacillus species (L. plantarum, L. 
bulgaricus  and  L. acidophilus) exerted antifungal and anti-aflatoxin activity 
against A. flavus. Guorama & Bullerman (1995) proposed in their first study that 
the inhibitory activity was caused by a low molecular weight inhibitory compound. 
When investigating the commercially available starter culture they discovered that 
a Lactobacillus casei subsp. pseudoplantarum was responsible for the inhibitory 
activity. The activity was sensitive to treatments with the proteolytic enzymes 
trypsin and α-chymotrypsin, and their conclusion was that the activity was due to 
the production of a small peptide of less than 1 kDa. The activity was not 
investigated or characterized further. The anti-aflatoxigentic properties of lactic 
acid bacteria has since then found another focus since it has been shown that 
several types of fungal toxins adhere to cells of lactic acid bacteria (Haskard et al., 
2001; El-Nezami et al., 2002).  
 
Only two publications report the purification of antifungal proteinaceous 
compounds from lactic acid bacteria. Okkers et al. (1999) purified and 
characterized a medium length peptide TV35b from Lactobacillus pentosus with 
fungistatic effect against Candida albicans. They discovered that the peptide 
caused reduction in growth of Candida albicans and induction of pseudo hyphae. 
The peptide was apparently not tested for activity against moulds.  
 
We found that a proteinaceous compound produced by Lactobacillus 
coryniformis subsp. coryniformis strain Si3 had antifungal effect against several 
moulds and against the yeasts Debaromyces hansenii and Kluyveromyces 
marxianus (II). The peptide was small (approx 3kDa), heat stable, active in the pH 
range 3-6 and totally inactivated by proteinase K or trypsin (II). The same 
characteristics can be found among bacteriocins of subclass II (Nes & Holo, 2000).   19 
 
The production of the antifungal peptide followed the same kinetics as that of 
several bacteriocins (Figure 1). The production kinetics of the bacteriocins 
amylovorin L471, produced by Lactobacillus amylovorus (Callewaert et al., 1999), 
Lactosin S from Lactobacillus sake (Mørtvet-Abildgard et al., 1995) and the 
fungistatic peptide TV35b from Lactobacillus pentosus were all very similar 
(Okkers et al., 1999; Figure 1). 
 
When a Lactobacillus coryniformis strain Si3 culture was supplimented with 
either ethanol, formic or acetic acid the total amount of the antifungal peptide 
increased (II,  Figure 1). The same response was observed when cultures of 
Lactobacillus amylovorus producing amylovorin L471 were treated with ethanol 
or organic acids (Callewaert et al., 1999). During addition of ethanol or organic 
acids the total amount of the antimicrobial peptide increased, instead of showing a 
peak in production as seen without ethanol (Figure 1). The same effect was seen 
for the production of Lactosin S from Lactobacillus sake (Mørtvet-Abildgard et 
al., 1995). This suggests that the peptide is highly hydrophobic in nature and 
rapidly adsorbs to the producer cells or forms spontaneous aggregates. However, 
Nilsen, Nes & Holo (1998) found that the presence of ethanol was inhibitory to 
production of bacteriocins enterocin A and enterocin B from Enterococcus 
faecium. The authors speculate that ethanol attenuate the response to the induction 
factor. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. During normal growth, the kinetics of the production of the antifungal peptide 
from L. coryniformis strain Si3 and several bacteriocins of subclass II show similarities. The 
activity distinctly peaks at about 48 hours, and then rapidly decreases. When ethanol or 
organic acids are gradually added during growth, the activity remains high (II; Mørtvet-
Abildgard et al., 1995; Callewaert et al., 1999). 
 
To isolate the antifungal proteinaceous compound of strain Si3 several different 
purification techniques were used that gave information on the nature of the 
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peptide. However, we were not able to purify the protein or determine its amino 
acid composition. The reason might be that the substance is unstable, loosing 
activity after two or three purification steps or simply after storage (II), or that the 
activity is mediated by a combination of peptides, not active on their own. Similar 
results have been seen with bacteriocins where activity requires a complementary 
peptide (Anderssen et al., 1998; Moll et al., 1998). The observed hydrophobic 
nature of the antifungal peptide might also be the reason for the problems that 
occurred, since there is a possibility that a hydrophobic peptide might bind 
strongly to glass or plastic material during growth and purification. Lactobacillus 
coryniformis strain Si3 also had antibacterial activity against several closely 
related species at pH values below 4.5 (unpublished results).  
 
Low molecular weight compounds 
Several authors have reported the detection of antifungal low molecular weight 
compounds, but the number of purified and chemically characterized compounds 
is still low. Several antifungal low molecular weight compounds were detected in 
this work, and they will be described and discussed in relation to the existing 
literature. This chapter also includes an overview of the methods that were used in 
this work to isolate low molecular weight inhibitory compounds. 
 
Reuterin 
Early during this work, we discovered that accidental addition of glycerol to the 
overlay assay (described in paper II) resulted in a dramatic increase of the 
inhibitory effect of Lactobacillus coryniformis strain Si3 against several 
filamentous fungi and yeast. We also observed that fungi, not inhibited or inhibited 
to a limited extent by the “normal” antifungal effect of strain Si3, suddenly were 
inhibited when glycerol was present in the overlay assay (IV). LAB lack the 
oxidative pathway of glycerol degradation, hence glycerol can not be metabolised 
as a sole carbon source (Slininger, Bothast & Smiley, 1983). According to the 
literature, the only pathway for glycerol degradation present in lactic acid bacteria 
goes through the intermediate state of 3-hydroxypropionaldehyde (Reuterin, 3-
HPA). 
 
Reuterin, a broad-spectrum antimicrobial substance originally described from 
Lactobacillus reuteri, is one of the most intensively studied low molecular weight 
inhibitory compounds (Talarico et al., 1988; Axelsson et al., 1989; Chung et al., 
1989; Nakanishi, 2002). Reuterin is produced from glycerol by starving cells under 
anaerobic conditions, and the active compound reuterin is in fact an equilibrium 
mixture of monomeric, hydrated monomeric and cyclic dimeric forms of 3-HPA 
(Talarico  et al., 1988). Reuterin is active against several different types of 
microorganisms including gram-positive and gram-negative bacteria, yeast and 
fungi. Antifungal activity was shown against species of Candida,  Torulopsis, 
Saccharomyces, Aspergillus and Fusarium however, little data supporting this 
claim was provided (Chung et al., 1989).  
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The antifungal effect of the addition of glycerol to L. coryniformis strains has 
been investigated in this work. The results clearly showed a dramatic increase in 
activity when glycerol was present in the substrate (IV). During isolation of 
glycerol metabolites from L. coryniformis we detected equal amounts of 3-
hydroxypropionic acid and 1,3-propanediol, and only trace amounts of 3-HPA 
(IV), which is similar to what Sobolov & Smiley (1960) found for Lactobacillus 
sp. strain 208-A. They proposed a mechanism for breakdown of glycerol by 
lactobacilli by dehydration of glycerol to 3-HPA (Sobolov & Smiley, 1960), that 
further might be oxidized to 3-hydroxypropionic acid or reduced to 1,3-propandiol 
(Figure 2). The first step is catalysed by glycerol dehydratase and the second step 
by a NAD-linked reductase, whereas the oxidation to 3-hydroxypropionic acid 
appears to be spontaneous (Sobolov & Smiley, 1960; Savaugeot, 2002a). The 
glycerol dehydratase of L. reuteri has been purified and characterized (Talarico & 
Dobrogosz, 1990), but they did not present any genetic data supporting the results. 
However, recent genetic and biochemical results of Sauvageot et al. (2002a, b) 
suggest that the structure of lactobacilli glycerol/diol dehydratases is similar to the 
corresponding enzymes found in other bacterial genera. 
 
 
 
 
CH2O H        H 2O   CH2O H            C H 2OH 
 
CHOH            CH2            CH2 
 
CH2O H             C H O             C H 2OH 
 
Glycerol               3-HPA        1,1,3-propanediol 
 
 
 
 
              CH2OH  
                             
              CH2 
        
              COOH   
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Figure 2. Metabolic pathway for the production and further reduction or oxidation of 3-
HPA from glycerol. Adopted from Slininger, Bothast & Smiley (1983). 
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The production of reuterin (3-HPA) has earlier been reported from L. brevis and 
L. buchneri (Schütz & Radler, 1984), L. collinoides (Claisse & Lonvaud-Funel, 
2000) and L. coryniformis (Nakanishi et al., 2002; IV). Two isofunctional 
enzymes, glycerol dehydratase and diol dehydratase, catalyse the conversion of 
glycerol to 3-HPA, but the glycerol dehydratase has greater affinity for glycerol 
(Sauvageot, 2002a, b). Sauvageot et al. (2002a) proposed that three genes 
(pduCDE), encoding the diol dehydratase of Lactobacillus collinoides, are 
responsible for the first metabolic step in the transformation of glycerol to 3-HPA, 
L. collinoides. This was further supported by biochemical data (Sauvageot et al. 
2002b). While investigating the presence of diol/glycerol dehydratase genes in L. 
coryniformis Si3 we discovered that Si3 also has a pdu operon containing similar 
genes as the L. collinoides operon (IV).  
 
Purification of antifungal low molecular weight compounds 
In our work, purification of hydrophobic low molecular weight inhibitory 
compounds from cell free supernatants of LAB cultures was achieved through a 
two-step purification procedure including solid phase extraction (SPE) and C18-
column high pressure liquid chromatography (HPLC) (Figure 3). The hydrophilic 
water phase was not further evaluated in this work. 
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Figure 3. Purification scheme for isolation of antifungal low molecular weight 
compounds from lactic acid bacteria. Sterile filtered supernatant of LAB is 
separated on a solid phase extraction column. The hydrophobic fraction is further 
separated on a C18 reversed phase column and fractions are collected in a 96 well 
microtiter plate. The antifungal activities of the different fractions are evaluated 
against the indicator fungus Aspergillus fumigatus (I, III).  (ACN = Acetonitrile)  
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Fractions with inhibitory activity against the indicator fungus A. fumigatus were 
further purified in a second preparative HPLC run with a porous graphite carbon 
column. Structures of antifungal compounds isolated during the second HPLC 
were determined using nuclear magnetic resonance (NMR) spectroscopy and mass 
spectrometry (MS; I, III; Ström et al. 2002). The bioassay-guided isolation of 
antifungal compounds was highly reproducible, and patterns of inhibition clearly 
indicative of the compounds produced. Different species of lactic acid bacteria, 
gave specific inhibition patterns. This might in the future be developed to a 
“chemo-taxonomic” fingerprint method for evaluating new antifungal lactic acid 
bacteria. (Figure 4, I, unpublished results). 
 
 
 
 
 
Figure 4. Overview of the antifungal activities found in the microtiter plate well assay after 
partial purification of LAB supernatants. Several distinct areas with antifungal activity are 
found corresponding to different low molecular weight compounds. The cyclic dipeptide 
cyclo(Phe-4-OH-Pro) is found in fractions C10-C12, cyclo(Phe-Pro) and phenyllactic acid 
in fractions D9-D12  and lactic acid in fractions B10-B12. New antifungal cyclic dipeptides 
are found in fractions C7-C9. Fatty acids are found in fractions E5-E7 and E9-F9. The 
remaining wells with antifungal activity contain unknown substances. Arrows indicates 
movement of fraction collector (I, III, unpublished results). 
 
Fatty acids 
Using the bioassay guided isolation protocol presented in figure 3 we discovered 
several hydroxylated fatty acids with antifungal activity from Lactobacillus 
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plantarum MiLAB 14 (III). Prior to our investigations, no reports on the 
antifungal activity of hydroxylated fatty acids produced by LAB were available. 
The fatty acids from MiLAB 14, 3-hydroxydecanoic acid (myrmicacin, 3-HDA), 
3-hydroxydocecanoic acid, 3-hydroxytetradecanoic acid and 3-hydroxy-5-cis-
dodecenoic acid were isolated from the supernatant (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Structure of four fatty acids detected in the supernatant of L. plantrum 
strain MiLAB 14; I, 3-hydroxydecanoic acid (myrmicacin, 3-HDA),   
II, 3-hydroxydodecanoic acid, III, 3-hydroxytetradecanoic acid, IV, 3-hydroxy-5-
cis-dodecenoic acid. 
 
Some lipolytic lactic acid bacteria can under certain conditions produce 
significant concentration of fatty acids with antimicrobial activity, that also 
contributes to the sensory quality of fermented foods (Earnshaw, 1992). Rao & 
Reddy (1984) reported the production of several fatty acids from cultures of lactic 
acid bacteria in fermented milk. While investigating straight-chained fatty acids, 
Woolford (1975) found that antimicrobial activity increases with chain length. 
Caprylic (C8) acid and longer fatty acids are generally the most effective (except 
hendecanoic, C11). Woolford (1975), noted that acids longer than 10 carbons were 
difficult to solve in water solutions. Baird-Parker (1980) also concluded that the 
antimicrobial activity of organics acids generally increased with chain length, but 
due to low solubility in water, aliphatic acids longer than C10 or C11 were not as 
effective as antimicrobial compounds. Kabra (1983) on the other hand found that 
fatty acids with 12-16 carbons were the most effective and exhibited detergent-like 
properties. We observed that the hydroxylated fatty acid with 12 carbons had the 
strongest antifungal activity (III). 
 
Bergsson et al., (2001) investigated the effect of fatty acids and monoglycerides 
on the growth of Candida albicans. They found that when yeast cells were treated 
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with 10 mM of the fatty acids, it was only capric (C10) and lauric (C12) acid that 
inhibited the yeast, which is in agreement with the data of Woolford (1975). 
Corsetti et al. (1998) discovered that a Lactobacillus sanfrancisco isolate produced 
a mixture of organic acids with antimould activity. Caproic (C6) acid played a key 
role, but other acids such as propionic, butyric and valeric acids also contributed to 
the inhibitory effect. 
 
We found that the hydroxylated fatty acids had strong antifungal activity against 
a broad spectrum of yeasts and moulds (III). The minimum inhibitory 
concentration (MIC) of 3-hydroxydecanoic acid was between 10 and 100 µg ml
-1, 
of 3-hydroxydodecanoic acid between 10 and 50 µg ml
-1, and of   
3-hydroxytetradecanoic acid between 10 and >100 µg ml
-1 against moulds and 
yeasts (III). This could be compared with standard antifungal drugs, e.g. 
amphoteracin B that inhibits fungal growth at concentrations in the µg ml
-1 range 
(McGinnis & Rinaldi, 1991; Frändberg et al. 2000). Yeasts were generally more 
sensitive to the hydroxylated fatty acids. 
  
Production of hydroxylated fatty acids followed bacterial growth, indicating that 
they do not result from cell lysis (III). The metabolic role of these hydroxylated 
fatty acids is not clear. Whether or not they are produced as antimicrobial agents 
was not possible to conclude from the data obtained in this work.  
 
Interestingly, Schildknecht & Koob (1971) isolated β-hydroxydecanoic acid 
(myrmicacin, β-HDA, 3-HDA) from gland secretions of the South American leaf-
cutting ant Atta sexdens. It was assumed that β-hydroxydecanoic acid prevents 
germination and growth of collected seeds and unwanted fungal spores. Later 
Schildknecht  et al, (1973) reported that the compounds phenylacetic acid, 
indolylacetic acid and L-β-hydroxydecanoic acid (myrmicacin) from the 
metathoric glands of Atta Sexdens, besides being antifungal also have auxin 
activities. These substances might act as growth inhibitors at high concentrations 
(against contaminating microorganisms and plants) and growth stimulators at low 
concentrations. The antifungal effect is vaguely documented and the sample used 
to investigate antimicrobial activity, secrete taken directly from the metathorical 
glands of another South American leaf-cutting ant Myrmica rubida, possibly 
contained a mixture of organic acids (Maschwitz, Koob & Schildknecht, 1970). 
The antifungal effect of myrmicacin was also shortly discussed in another 
publication, but very few data supporting this effect were presented (Schildknecht 
& Koob, 1971).  
 
 
Cyclic dipeptides and other low molecular weight inhibitory compounds 
Niku-Paavola et al. (1999) discovered new types of antimicrobial compounds 
from the culture filtrate of Lactobacillus plantarum VTT E-78076. The active 
fraction included benzoic acid, 5-methyl-2,4-imidazolidinedione 
(methylhydantoine), cyclo(glycyl-L-leucyl) (Figure 6c), and tetrahydro-4-hydroxy-
4-methyl-2H-pyran-2-one (mevalonolactone). Ström et al. (2002), recently 
reported the production of two cyclic dipeptides cyclo(Phe-Pro) and cyclo(Phe-  27 
 
OH-Pro) (Figure 6a, 6b) from the supernatant of MiLAB 393. The antimicrobial 
effect of several different cyclic dipeptides has been investigated (Graz et al., 
1999; 2001). The present study revealed the possibility that cyclo(Phe-Pro) and 
cyclo(Phe-OH-Pro) are also produced by strains of Pediococcus pentosaceus, 
Lactobacillus sakei and Lactobacillus coryniformis (I), and thus might be common 
LAB metabolites. Ström et al. (2002), speculate whether these cyclic dipeptides 
are in fact involved in a quorum sensing mechanism for the bacteria, which has 
been seen with similar compounds from Pseudomonas spp. The cyclic dipeptides 
have antifungal activity at mg ml
-1 concentrations, and hence are much less 
effective than the hydroxylated fatty acids discovered in this work. 
 
 
 
a .                   b .  
 
 
c.  
 
 
Figure 6. Several cyclic dipeptides with antifungal activity have recently been purified 
from different strains of LAB.  5 a. cyclo(Phe-Pro) from Lactobacillus. plantarum MiLAB 
393,  Lactobacillus. coryniformis strain Si3; 5 b. cyclo(Phe-OH-Pro) from L. plantarum 
MiLAB 393 and L. coryniformis strain Si3; 5c, cyclo(Gly-Leu), from L. plantrum (Niku-
Paavola et al., 1999). 
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We have recently found that there are low concentrations of several cyclic 
dipeptides present in MRS (broth and agar) and other complex media for growth of 
lactic acid bacteria. However, these amounts are not themselves high enough to 
exert antimicrobial activity in the applied bioassays (Unpublished results). 
 
Lavermicocca et al. (2000) reported the production of phenyllactic acid and 4-
hydroxyphenyllactic acid from L. plantarum 21b, which has antifungal activity 
against several species of filamentous fungi. 3-Phenyllactic acid has also been 
identified from culture supernatants of Lactobacillus plantarum MiLAB 393 
(Ström et al., 2002, Figure 7) and from Lactobacillus coryniformis strain Si3 (I). 
Later studies revealed the possibility that 3-Phenyllactic acid is also produced by 
strains of Pediococcus pentosaceus and Lactobacillus sakei (I) and thus might be a 
common LAB metabolite. In common with the cyclic dipeptides, phenyllactic acid 
is only active at high concentrations against yeasts and moulds. However, they will 
most certainly act in synergy with other compounds produced by lactic acid 
bacteria and contribute to the overall antifungal effect. 
 
 
 
 
 
L-phenyllactic  acid            D-Phenyllactic  acid 
 
 
Figure 7. Structural form of L and D- phenyllactic acid isolated from 
Lactobacillus plantarum strain Mi393, and Lactobacillus coryniformis strain Si3 
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Summary of the current knowledge of antifungal compounds 
from LAB 
One objective of this work was to give a more complete picture of the complex 
nature of antifungal activity of LAB. A summary of the antifungal compounds 
produced by LAB is thus presented in figure 8. Given the limited resources spent 
to date on investigations of antifungal LAB, it is highly likely that many new 
antifungal compounds await discovery. It is also obvious that combinations of 
LAB species or strains that produce different antifungal compounds could be 
useful as novel biopreservatives. Possible use of antifungal LAB will also depend 
on whether these organisms and their metabolites will be seen as safe by the 
regulatory authorities.  
 
 
 
 
 
Figure 8. Summary of current knowledge of the complex antifungal activities of lactic acid 
bacteria.  
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Concluding remarks 
 
The research field of antifungal lactic acid bacteria is still novel. Most publications 
on antifungal activity of lactic acid bacteria merely illustrate the activity, but rarely 
identify active compounds or other reasons for the inhibitory activity. To date, the 
majority of antifungal substances purified from LAB have been low molecular 
weight compounds. Only two publications have presented clear evidence for the 
production of antifungal peptides/proteins. This might be because they are more 
rare than low molecular weight inhibitory compounds or much more difficult to 
purify. While reviewing the literature, it appeared that there has to be a large 
number of very interesting strains, with strong antifungal effect, stored in several 
culture collections around the world. A re-evaluation of these isolates, with proper 
controls and purification methods, is needed, to better understand how LAB 
inhibits fungi. 
 
Studying interactions between lactic acid bacteria and fungi is no simple matter, 
especially since the bacteria produce fermentation end products that themselves are 
active to a certain extent, or act synergistically with specific antifungal 
compounds. In nature, this is of importance for the outcome of microbial 
interactions. Obviously, each antimicrobial compound produced during lactic acid 
bacteria fermentation provides an additional hurdle for spoilage organisms to 
overcome in food or other biotechnological applications. 
 
This work has identified several antifungal compounds, some of which has not 
previously been reported from lactic acid bacteria. The majority were low 
molecular weight compounds, e.g. hydroxy fatty acids, 3-hydroxypropionaldehyde 
and cyclic dipeptides, but a proteinaceous compound has also been found. Initially, 
we believed that it was possible to find one, maybe two active compounds from 
each isolate, but in fact many more was found. The large number of active 
compounds probably contributes to a highly complex mode of action. 
 
The results obtained in this study leads to several important questions to be 
answered by further research; why are these compounds produced, what kind of 
effect do they really have on the fungus, and are they applicable to food and feed 
preservation? 
 
In more detail: 
•  Determine the antimicrobial effect against a broader spectrum of 
organisms, e.g. bacteria and viruses. 
•  Investigate the role of cyclic dipeptides and hydroxy fatty acids in the 
metabolism of lactic acid bacteria. 
•  Evaluate possible synergistic effects of cyclic dipeptides, phenyllactic 
acids, and hydroxy fatty acids from antifungal lactic acid. 
•  Investigate if it is possible to optimise the production of cyclic dipeptides 
and hydroxy fatty acids, and determine whether other strains of lactic acid 
bacteria produce similar substances.   31 
 
•  Elucidate molecular response of the fungus when treated with cyclic 
dipeptides, antifungal peptides, reuterin and the hydroxy fatty acids. 
•  Investigate if the lactic acid bacteria included in this study can be used for 
application in food and feed systems. 
•  Determine the amino acid sequence of the antifungal peptide(s) produced 
by Lactobacillus coryniformis strain Si3, either through purification of the 
substance or cloning. There are several interesting aspects to investigate;  
o  Similarities to bacteriocins produced by lactic acid bacteria 
o  The mode of action of the peptide(s) 
o  Gene structure and regulation 
 
 
This thesis will hopefully inspire other researchers to elucidate the mode of action 
of antifungal LAB, as well as to develop alternative means of controlling fungal 
growth in food and feeds. 
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